Estetrol review: profile and potential clinical applications.
In this review paper, the existing information on the human fetal steroid estetrol (E4) has been summarized. In the past, E4 was considered as a weak estrogen and interest disappeared. However, recent new research has demonstrated that E4 is a potent, orally bioavailable, natural human fetal selective estrogen receptor modulator, since it acts in the rat as an estrogen on all tissues investigated except breast tumor tissue, where it has estrogen antagonistic properties in the presence of estradiol. Based on its safety data, its pharmacokinetic properties, its pharmacological profile and the results of first human studies, E4 may be suitable as a potential drug for human use in applications such as hormone replacement therapy (vaginal atrophy, hot flushes), contraception and osteoporosis. Additional areas worth exploring are the treatment of breast and prostate cancer, hypoactive sexual desire disorder and topical use (wrinkles) in women, auto-immune diseases, migraine, cardiovascular applications and the treatment of selected obstetric disorders.
Coelingh Bennink
H J T
HJ
Pantarhei Bioscience, Zeist, The Netherlands.
Holinka
C F
CF
Diczfalusy
E
E
D004953:Estetrol / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D020847:Estrogen Receptor Modulators / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy / Q000379:methods*; D005260:Female; D019584:Hot Flashes / Q000188:drug therapy*; D006801:Humans; D008593:Menopause / Q000187:drug effects; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors; D018570:Risk Assessment; D012449:Safety; D016387:Women's Health
D020847:Estrogen Receptor Modulators; D011960:Receptors, Estrogen; D004953:Estetrol